Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, although the Methicillin-resistant (MRSA) drugmarket is currently ...
MRSA is a potentially dangerous type of staph bacteria that is resistant to certain antibiotics and may cause skin and other infections. Recent data show that Americans visit the doctor approximately ...
Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in Spanish hospitals and community long-term-care facilities (LTCFs). This longitudinal study was performed in community LTCFs to ...
Methicillin-resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a new study. It was the widespread use of ...
Vancomycin use has increased dramatically worldwide since the mid-1980s, largely as a result of empirical and directed therapy against burgeoning methicillin-resistant Staphylococcus aureus (MRSA) ...
The introduction of methicillin into clinical practice is not what caused the emergence of methicillin resistant Staphylococcus aureus (MRSA), report researchers. According to a collaborative study by ...
Does piperacillin/tazobactam cover methicillin-sensitive Staphylococcus aureus (MSSA) infection? Or should we add a penicillinase-resistant penicillin to that ...
Scientists in Germany have discovered a new drug to combat one of the most dangerous antibiotic-resistant bacteria in the world, methicillin-resistant Staphylococcus aureus (MRSA), and it's buried ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback